NCT00367354

Brief Summary

The purpose of this project is to analyze the respiratory motion process as relevant in cardiac MRI imaging and apply the results for development of improved imaging methods and software correction. To accomplish this, we will develop an imaging protocol for monitoring respiratory motion. The imaging protocol will be limited to less than five minutes of acquisition time so it may be performed as "piggyback" acquisition following clinically prescribed imaging studies on pediatric and adult cardiac MRI patients, but will also be applied to normal healthy volunteers. Hypothesis Characterization of respiratory motion will help improve image quality by allowing optimized scan acquisition and retrospective correction of acquired data.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

August 18, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 22, 2006

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
Last Updated

December 9, 2014

Status Verified

December 1, 2014

Enrollment Period

3.8 years

First QC Date

August 18, 2006

Last Update Submit

December 8, 2014

Conditions

Keywords

Imaging TechnologyCardiology

Outcome Measures

Primary Outcomes (1)

  • cardiac motion reduction in cardiac MRI images

    throughout study

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

35 healthy volunteers (21 years or older) and 25 cardiac MRI patients of different age groups.

You may qualify if:

  • We will recruit two groups of patients - 35 healthy volunteers (21 years or older) and 25 cardiac MRI patients of different age groups.
  • We wish to recruit cardiac patients from Children's Healthcare of Atlanta into five (5) different categories defined by the overall characteristics of breathing motion. The categories are:
  • neonates/infants (shallow belly breathing)
  • young children (unable to do controlled breathing or breath-holding on command, up to approximately 7 years of age)
  • older children capable of controlled breathing/breath-holding on command (approximately 8-12 years of age)
  • teenagers/adolescents/young adults (ages 13 through 17)
  • adults (18 and older) These categories may be adjusted or modified during the project as deemed appropriate based on the analysis results.
  • We will recruit 10 - 35 healthy volunteer subjects for scans to define the MRI imaging protocol for respiratory motion monitoring. Healthy subjects are defined as those individuals who do not have a prior history of heart or lung disease nor are currently diagnosed with heart or lung disease. This information will be obtained verbally during the subject screening process.

You may not qualify if:

  • subjects with pacemakers, medical implants, aneurysm clips, or imbedded metal fragments will be excluded because of potential effects of the magnetic field
  • women who are pregnant or who may be pregnant will be excluded because of the potential of a high level of RF power deposition on the fetus
  • subjects who may experience claustrophobia will be excluded because of their inability to remain in the magnet for the time required to complete the exam

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory University Hospital

Atlanta, Georgia, 30322, United States

Location

MeSH Terms

Conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • William Mahle

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 18, 2006

First Posted

August 22, 2006

Study Start

August 1, 2006

Primary Completion

June 1, 2010

Study Completion

July 1, 2011

Last Updated

December 9, 2014

Record last verified: 2014-12

Locations